NCT02811731View on ClinicalTrials.gov

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Hypertension
Interventions
DRUG

CKD-330 16/5mg - B

DRUG

Candesartan 16mg and Amlodipine 5mg

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02811731 - Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B | Biotech Hunter | Biotech Hunter